| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIO | Bio-Rad A Common Stock | +Options Exercise | $0 | +433 | +13.97% | $0.00 | 3,532 | Sep 2, 2021 | Direct | F1 |
| transaction | BIO | Bio-Rad A Common Stock | -Tax liability | -$123,866 | -150 | -4.25% | $825.77 | 3,382 | Sep 2, 2021 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIO | Restricted Stock Units | -Options Exercise | $0 | -433 | -24.99% | $0.00 | 1,300 | Sep 2, 2021 | Bio-Rad A Common Stock | 433 | $0.00 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | Shares of Class A common stock acquired on the vesting of restricted stock units. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. |
| F3 | On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |